Daicel Corporation
4202・Prime Market・Chemicals
Daicel Corporation4202
Daicel Corporation4202
Reference Indicators
Market Cap
3,957¥100M
P/E (Forecast)
7.7x
P/B
1.1x
Dividend Yield (Forecast)
4.05%
ROE
2.9%
EV/EBITDA
7.4x
Financial Summary
Unit: ¥M
| Item | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 |
|---|---|---|---|---|---|
Net Sales | 467,937 | 538,026 | 558,056 | 586,531 | 579,629 |
Cost of Sales | 329,329 | 392,214 | 398,776 | 421,785 | 433,340 |
Gross Profit | 138,607 | 145,811 | 159,280 | 164,746 | 146,288 |
SG&A Expenses | 87,910 | 98,303 | 96,887 | 103,735 | 104,219 |
Operating Income | 50,697 | 47,508 | 62,393 | 61,011 | 42,069 |
Non-operating Income | 8,694 | 7,637 | 8,952 | 7,996 | 8,803 |
Non-operating Expenses | 2,100 | 3,111 | 2,949 | 6,687 | 5,742 |
Ordinary Income | 57,291 | 52,035 | 68,396 | 62,320 | 45,130 |
Extraordinary Income | 1,878 | 5,519 | 11,354 | 20,459 | 20,030 |
Extraordinary Losses | 12,886 | 2,587 | 3,718 | 17,279 | 38,991 |
Pre-tax Income | 46,283 | 54,967 | 76,032 | 65,499 | 26,169 |
Income Taxes | 14,229 | 13,326 | 19,487 | 15,022 | 14,722 |
Net Income | 31,254 | 40,682 | 55,834 | 49,480 | 10,180 |
EBITDA | 78,892 | 79,083 | 96,096 | 102,384 | 85,412 |
Gross Margin | 29.6% | 27.1% | 28.5% | 28.1% | 25.2% |
Operating Margin | 10.8% | 8.8% | 11.2% | 10.4% | 7.3% |
ROA | 4.5% | 5.3% | 6.7% | 6.1% | 1.2% |
ROE | 12.3% | 14.3% | 17.1% | 13.8% | 2.9% |
Segment Performance
Unit: ¥M
2026
| Segment | Net Sales | Operating Income | Operating Margin |
|---|---|---|---|
| メディカル・ヘルスケア事業 | 16,227 | 427 | 2.6% |
| スマート事業 | 37,746 | 536 | 1.4% |
| セイフティ事業 | 104,164 | 6,095 | 5.9% |
| マテリアル事業 | 161,324 | 14,953 | 9.3% |
| エンジニアリングプラスチック事業 | 254,718 | 19,151 | 7.5% |
| その他 | 5,448 | 904 | 16.6% |